Minimal Invasive Volar Plating Versus Cast Immobilization for Treatment of Stable Non-displaced Distal Radial Fractures.
NCT ID: NCT05015556
Last Updated: 2022-10-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
90 participants
INTERVENTIONAL
2022-09-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Distraction Osteogenesis for Distal Radius Fractures vs. Volar Plating
NCT03635060
Cost-effectiveness, Volar Locking Plate or Non-operative Treatment Distal Radius Fracture
NCT06067074
Distal Radius Fractures in Patients Over 65 Years, Operation or Cast?
NCT02336035
The Effect of Intraoperative Brachioradialis Release
NCT06631651
Distal Radial Fractures in Adult Patients: 4 Weeks Versus 6 Weeks of Cast Immobilisation Following Closed Reduction.
NCT05012345
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
RZ Tienen, Dr Goorens Level 4 hand surgeon
Inclusion criteria:
* Stable distal radial fractures (volar tilt \<10° dorsal tilt, \<2mm impaction, \<2mm articular depression)
* 18 - 65 years, professional active
Exclusion criteria:
* associated lesions, open fractures, unstable, displaced fractures
* neurological disorder affecting the upper limb, history of wrist lesion involving the same wrist, dementia, substance abuse, severe psychiatric disorder and previous injured contralateral wrist
Treatment
1. Cast treatment: 6 weeks with 1 plaster exchange of after 2 weeks
2. Minimal invasive plating: no cast
Followup 2 weeks, 6 weeks, 3 months, 6 months, 1 year
Primary PROM:
* Cost effectiveness: QALY SF-36
* Direct costs: surgery, hospitalisation, follow-up consultations, imaging, medication, wound care, nurse cost, physiotherapy cost
* Indirect costs: loss of productivity (SF-HLQ)
* Health insurances costs
* Confounding factors
* Independent vs servant
* Insurance?
* Work type?
* Age, sex, dominance
* Work absence, professional recuperation
* Recreational sport resumption
Secondary PROM
* ROM (F/E/RD/UD/P/S)
* Grip strength (Jamar)
* Pain (VAS)
* DASH scare, PRWE score
* Satisfaction (VAS), would you do it again?
* RX ulna variance, radial tilt
* complications
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Casting
Casting of the distal radius for 6 weeks
No interventions assigned to this group
Minimal invasive volar plating
Muscle sparing osteosynthesis, no casting postoperatively
Minimal invasive volar plating
Muscle sparing osteosynthesis, no casting postoperatively
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Minimal invasive volar plating
Muscle sparing osteosynthesis, no casting postoperatively
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 - 65 years, professional active
Exclusion Criteria
* neurological disorder affecting the upper limb, history of wrist lesion involving the same wrist, dementia, substance abuse, severe psychiatric disorder and previous injured contralateral wrist
16 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Goorens Chul Ki
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Goorens Chul Ki
M.D., Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lieselot Brepoels, MD
Role: STUDY_DIRECTOR
RZ Tienen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of orthopaedics RZ Tienen
Tienen, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
chul ki goorens, md
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
109
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.